www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Gunmen kill 4 in western Baghdad    48 confirmed dead in Peru air crash, 52 survive    China issues White Paper on gender equality    Agassi plans to rest after US Open    US, S.Korea discuss six-party talks    Intel unveils new chip architecture    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
S.Korean scientists clone pigs for cancer cure supplements
www.chinaview.cn 2005-08-24 16:44:28

    SEOUL, Aug. 24 (Xinhuanet) -- South Korean scientists said Wednesday that they have successfully cloned pigs that can produce a protein used as a supplement to cancer treatment.

    The research was conducted by scientists from Chungnam National University in Daejeon, about 160 km south of Seoul, and MGenbio, a local biotech company, reported South Korean Yonhap News Agency.

    The scientists injected a human GM-CSF gene into somatic cells of a pig and created 1,6000 cloned embryos by implanting those cells into unfertilized eggs with their nuclei removed.

    Then, the embryos were planted into the wombs of eight surrogate sows which gave birth to six pigs, four of which were born successfully transformed, said Yonhap.

    GM-CSF is a protein which promotes the growth of white blood cells. It is used in treating anemia and leukemia as well as in bone marrow transplants and chemotherapy.

    When fully grown, the four cloned Land Race pigs will be able to secrete the protein GM-CSF in their milk, paving the way for mass production of the high-priced cancer treatment supplement.

    Currently, one gram of GM-CSF is sold for as high as 600,000 US dollars.

    However, according to MGenbio President Park Kwang-wook, it may take up to 15 years to commercialize the technology.

    "Ten to 15 years may be needed to conduct clinical tests and win approval from the authorities," Park was quoted by Yonhap as saying.   Enditem

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.